Urinary testing for TMPRSS2: ERG and PCA3 improve detection of aggressive prostate cancer

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

IMPORTANCE Potential survival benefits from treating aggressive (Gleason score ≥7) early-stage prostate cancer are undermined by harms from unnecessary prostate biopsy and overdiagnosis of indolent disease.

OBJECTIVE To evaluate the a priori primary hypothesis that combined measurement of PCA3...